Abiomed (MM)
   
To register click here

Abiomed Stock Price ABMD

Company Description : The Company is a provider of medical devices in circulatory support and offers a continuum of care in heart recovery to acute heart failure patients. url: www.abiomed.com

Name:
Abiomed (MM)
Symbol:
NASDAQ:ABMD
Stock Market:
NASDAQ Stock Market
Type:
Common Stock
ISIN:
Description:
 Change (p)Change (%)CurBidAskHighLowOpenVolumeTimeA
0.352.7413.127.2614.8313.2611.0412.692813616:58:57
To register Click hereRegister for free Abiomed stock prices.

Abiomed gets FDA 501(k) clearance for Imeplla 2.5 cardiac assist device : BOSTON (Thomson Financial) - Abiomed Inc. Monday said it has received a 501(k) clearance from the Food and Drug Administration for its Impella 2.5 cardiac assist device. The 510(k) clearance allows Abiomed to begin...

Free Abiomed Stock Charts

Abiomed Historical Stock Chart
Abiomed Historical Stock Chart
Abiomed Monthly Stock Chart
Abiomed Monthly Stock Chart
Abiomed Intraday stock chart
Abiomed Intraday stock chart

To register Click hereRegister for FREE streaming stock charts featuring overlays, annotations and more than 80 different studies including Level 2 Scope and Average True Range.

Get the Latest Abiomed stock Price, quotes, trades and FREE Abiomed stock charts, company information, annual reports, market news and announcements from ADVFN. We offer Intraday and historical stock prices for Abiomed (ABMD) and other NASDAQ Stock Market listed companies as well as company financials, Level 2 Data and the latest investor information from our stock market Message Boards.

Abiomed News

Latest Abiomed News Headlines
DateTimeSource
Headline
06/02/20087:25AMTFNFAbiomed gets FDA 501(k) clearance for Imeplla 2.5 cardiac assist device
05/02/20089:56AMTFNFAbiomed shares rise after CMS OKs coverage for AbioCor replacement heart
03/28/200811:32AMTFNFAbiomed 'remains confident' on Impella 2.5 device 501(k) clearance
03/17/200811:14AMTFNFAbiomed gets conditional FDA approval for Impella 2.5 study
02/07/20088:02AMTFNFAbiomed reports wider 3Q loss; revenue rose 24%, sees FY08 revenue $58M-$62M
01/24/200811:37AMTFNFAbiomed says 3 of 4 FDA questions on 510(k) submission for Impella 2.5 resolved
01/22/20089:48AMTFNFAbiomed's AbioCor artificial heart gets FDA supplement approval
12/19/20078:45AMTFNFAbiomed gets FDA approval for commercial distribution of iPulse in U.S.
12/12/20077:48AMTFNFAbiomed enters into strategic alliance with World Heart; takes investment stake
12/12/20077:00AMPRNUSWorldHeart Announces Strategic Alliance With Abiomed

Abiomed Company Information

 Sector  Turnover (m)  Profit (m)  EPS - Basic  PE ratio  Mkt Cap (m)  NMS 
  0.00 0.00   0.0 N/A
To register Click hereRegister for FREE access to the latest Abiomed company information and fundamental data for other USA Common Stock companies. More than 100 separate statistics including accounts payable / sales and inventory / sales.

Latest Abiomed Stock Trade

 Type  Size  Price  Date  Tr.Time  Units 
  300 13.12 10/10/2008 6:00PM USD


 



PLUS quotes are live. NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions :: Contact Us :: Request an Exchange :: Affiliate Scheme
Copyright1999-2008 ADVFN PLC. Copyright and limited reproduction :: Privacy Policy :: Investment Warning :: Advertise with us :: Data accreditations :: Investor Relations :: Press office :: Jobs
ADDITIONAL SERVICES AVAILABLE FROM ADVFN
Upgrade - Click here for more information on ADVFN premium services Money Words - ADVFN Financial Glossary Investor Training ADVFN Financial Bookshop Online Training Academy
31 site:2us nasdaq abmd081012 01:06 Stock Message Boards ( 2001 | 2002 | 2003 | 2004 | 2005 | 2005 | 2007 )